Table 4.
Percentage and events of CD15s− cells in CSC, CD44− and CD44+CD24+ subpopulations after treatment with compound 1.
| CSC | CD44− | CD44+CD24+ | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Control | 1 | p-Value | Control | 1 | p-Value | Control | 1 | p-Value | |
| % CD15s− | 7.17 ± 3.21 | 25.85 ± 2.21 | 0.0019 | 50.97 ± 5.74 | 72.94 ± 5.75 | 0.0094 | 4.36 ± 2.66 | 16.4 ± 1.56 | 0.0052 |
| Events CD15s− | 668 ± 33.94 | 443 ± 75.44 | 0.1758 | 444.67 ± 50.29 | 426.33 ± 105.67 | 0.8045 | 14 ± 2 | 13.67 ± 2.51 | 0.8666 |
Notes: Data are expressed as a mean from experiment performed in triplicate ± SD. Abbreviations: CSC, cancer stem cells.